Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cellsHERTLEIN, Erin; TRIANTAFILLOU, Georgia; BYRD, John C et al.Blood. 2010, Vol 116, Num 14, pp 2554-2558, issn 0006-4971, 5 p.Article

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. CommentaryHERTLEIN, Erin; BYRD, John C; CROOKS, Peter A et al.Blood. 2008, Vol 111, Num 9, issn 0006-4971, 4427, 4681-4689 [10 p.]Article

Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74⁺ B-cell MalignanciesYICHENG MAO; TRIANTAFILLOU, Georgia; GOLDENBERG, David M et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 347-356, issn 1078-0432, 10 p.Article

The Proteasome Inhibitor Carfilzomib Functions Independently of p53 to Induce Cytotoxicity and an Atypical NF-κB Response in Chronic Lymphocytic Leukemia CellsGUPTA, Sneha V; HERTLEIN, Erin; BYRD, John C et al.Clinical cancer research (Print). 2013, Vol 19, Num 9, pp 2406-2419, issn 1078-0432, 14 p.Article

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765HERMAN, Sarah E. M; GORDON, Amber L; HAMDY, Ahmed et al.Blood. 2011, Vol 117, Num 23, pp 6287-6296, issn 0006-4971, 10 p.Article

17-DMAG targets the nuclear factor-κB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibitionHERTLEIN, Erin; WAGNER, Amy J; WEST, Derek A et al.Blood. 2010, Vol 116, Num 1, pp 45-53, issn 0006-4971, 9 p.Article